Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study

We have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources we...

Full description

Bibliographic Details
Main Authors: Mohammad Nouri Sharikabad, Svetlana Skurtveit, Hilchen Thode Sommerschild, Kristine Olsen, Ingeborg Hartz, Rikke Wesselhoeft, Vidar Hjellvik, Lars Johan Hauge, Marte Handal
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/13/4/1075
_version_ 1797297850164445184
author Mohammad Nouri Sharikabad
Svetlana Skurtveit
Hilchen Thode Sommerschild
Kristine Olsen
Ingeborg Hartz
Rikke Wesselhoeft
Vidar Hjellvik
Lars Johan Hauge
Marte Handal
author_facet Mohammad Nouri Sharikabad
Svetlana Skurtveit
Hilchen Thode Sommerschild
Kristine Olsen
Ingeborg Hartz
Rikke Wesselhoeft
Vidar Hjellvik
Lars Johan Hauge
Marte Handal
author_sort Mohammad Nouri Sharikabad
collection DOAJ
description We have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources were (i) prescription data from the Norwegian Prescription Database linked to specialist health care diagnoses from the Norwegian Patient Registry and (ii) sleep disorder diagnoses from the Primary Health Care Database. Hypnotic drugs were defined as the sedative antihistamine alimemazine and the ATC group “Hypnotics and Sedatives” (N05C), excluding midazolam. In 2017, 2519 girls (16.5/1000) and 1718 boys (10.7/1000) were incident (new) users of hypnotic drugs. Most of these new users (82% of girls, 77% of boys) were referred to secondary health care, where the most frequent diagnoses were mental and behavioral disorders (51.8% of girls, 46.2% of boys), while only 3.2% received a specific sleep disorder diagnosis. The most common mental and behavioral disorders were “Neurotic stress-related disorders” among girls (27.4%) and “Behavioral and emotional disorders” among boys (23.6%). In conclusion, the trend of increasing hypnotic drug use among adolescents reflects the initiation of hypnotic drugs in a subgroup of the population with a higher disease burden, mainly due to psychiatric disorders, than the general population.
first_indexed 2024-03-07T22:26:23Z
format Article
id doaj.art-193a7bfe334c4b73b61f5b141702a884
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-07T22:26:23Z
publishDate 2024-02-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-193a7bfe334c4b73b61f5b141702a8842024-02-23T15:22:13ZengMDPI AGJournal of Clinical Medicine2077-03832024-02-01134107510.3390/jcm13041075Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based StudyMohammad Nouri Sharikabad0Svetlana Skurtveit1Hilchen Thode Sommerschild2Kristine Olsen3Ingeborg Hartz4Rikke Wesselhoeft5Vidar Hjellvik6Lars Johan Hauge7Marte Handal8Department of Drug Statistics, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayNorwegian Board of Health Supervision, 0213 Oslo, NorwayDepartment of Drug Statistics, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayChild and Adolescent Mental Health Southern Denmark, Mental Health Services in the Region of Southern Denmark, 5000 Odense C, DenmarkDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Mental Health and Suicide, Norwegian Institute of Public Health, 0213 Oslo, NorwayDepartment of Chronic Diseases, Norwegian Institute of Public Health, 0213 Oslo, NorwayWe have previously shown that the use of hypnotic drugs increased among young Scandinavians during 2012–2018. This study aimed to explore psychiatric and somatic morbidity among adolescent hypnotic drug users in a cohort study of 13–17-year-old individuals during 2008–2018 in Norway. Data sources were (i) prescription data from the Norwegian Prescription Database linked to specialist health care diagnoses from the Norwegian Patient Registry and (ii) sleep disorder diagnoses from the Primary Health Care Database. Hypnotic drugs were defined as the sedative antihistamine alimemazine and the ATC group “Hypnotics and Sedatives” (N05C), excluding midazolam. In 2017, 2519 girls (16.5/1000) and 1718 boys (10.7/1000) were incident (new) users of hypnotic drugs. Most of these new users (82% of girls, 77% of boys) were referred to secondary health care, where the most frequent diagnoses were mental and behavioral disorders (51.8% of girls, 46.2% of boys), while only 3.2% received a specific sleep disorder diagnosis. The most common mental and behavioral disorders were “Neurotic stress-related disorders” among girls (27.4%) and “Behavioral and emotional disorders” among boys (23.6%). In conclusion, the trend of increasing hypnotic drug use among adolescents reflects the initiation of hypnotic drugs in a subgroup of the population with a higher disease burden, mainly due to psychiatric disorders, than the general population.https://www.mdpi.com/2077-0383/13/4/1075hypnotics and sedativesmelatoninadolescentsleep disorderssleep disturbancesmental disorders
spellingShingle Mohammad Nouri Sharikabad
Svetlana Skurtveit
Hilchen Thode Sommerschild
Kristine Olsen
Ingeborg Hartz
Rikke Wesselhoeft
Vidar Hjellvik
Lars Johan Hauge
Marte Handal
Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
Journal of Clinical Medicine
hypnotics and sedatives
melatonin
adolescent
sleep disorders
sleep disturbances
mental disorders
title Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
title_full Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
title_fullStr Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
title_full_unstemmed Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
title_short Morbidity among Adolescent Hypnotic Drug Users in Norway: An Observational Population-Based Study
title_sort morbidity among adolescent hypnotic drug users in norway an observational population based study
topic hypnotics and sedatives
melatonin
adolescent
sleep disorders
sleep disturbances
mental disorders
url https://www.mdpi.com/2077-0383/13/4/1075
work_keys_str_mv AT mohammadnourisharikabad morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT svetlanaskurtveit morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT hilchenthodesommerschild morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT kristineolsen morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT ingeborghartz morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT rikkewesselhoeft morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT vidarhjellvik morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT larsjohanhauge morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy
AT martehandal morbidityamongadolescenthypnoticdrugusersinnorwayanobservationalpopulationbasedstudy